4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Intraoperative Assessment of Pulsatile Aneurysm Wall Motion During Endovascular Aneurysm Repair

Intraoperative Assessment of Pulsatile Aneurysm Wall Motion During Endovascular Aneurysm Repair

Study Description
Brief Summary:
Endovascular abdominal aortic aneurysm repair (EVAR) aims to reduce the risk of aneurysm (AAA) rupture by reducing the blood pressure transmitted to the wall of the aneurysm. Aneurysms that remain pressurized despite EVAR may continue to grow, therefore requiring additional surgical interventions. The purpose of this study is to infer the reduction of pressure transmitted to the aneurysm wall by using intraoperative ultrasound ('M-Mode') to assess the pulsatility of the aneurysm wall. The hypothesis is that intraoperative reduction in aneurysm wall pulsatility after EVAR will correlate with improved aneurysm sac size reduction.

Condition or disease Intervention/treatment
Abdominal Aortic Aneurysm Endovascular Abdominal Aortic Aneurysm Repair Ultrasound Diagnostic Test: Abdominal Aortic Aneurysm Sac Pulsatility

Detailed Description:

Endovascular abdominal aortic aneurysm repair (EVAR) aims to reduce the risk of aneurysm (AAA) rupture by reducing the blood pressure transmitted to the wall of the aneurysm. Unfortunately, this procedure is not always successful, and patients need to return to the operating room for further procedures because the aneurysm wall remains pressurized and the aneurysm continues to grow. Currently, there is no standard non-invasive way of measuring aneurysm pressure. The purpose of this study is to infer the reduction of pressure transmitted to the aneurysm wall by using intraoperative ultrasound ('M-Mode') to assess the pulsatility of the aneurysm wall. The hypothesis is that intraoperative reduction in aneurysm wall pulsatility after EVAR will correlate with improved aneurysm sac size reduction. This is clinically relevant because physiologic intraoperative feedback of aneurysm pressure may potentially influence surgical decision making in the future, reducing unnecessary re-interventions. This will also improve our understanding of the intraoperative physiologic response to EVAR.

Our primary research question is in patients receiving elective endovascular repair of abdominal aortic aneurysms (EVAR), does the change in intraoperative ultrasound estimated aneurysm wall pressure during EVAR correlate with aneurysm sac size reduction 1 year after surgery? Secondary objectives are to assess correlation between intraoperative ultrasound estimated aneurysm wall pressure and endovascular leaks and aneurysm-related re-interventions.

A prospective, observational, assessor-blinded and surgeon-blinded study will be conducted at the TOH Civic Campus in Ottawa, ON in order to satisfy the objectives of the study.

Study Design
Layout table for study information
Study Type : Observational
Estimated Enrollment : 20 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Intraoperative Assessment of Pulsatile Aneurysm Wall Motion During Endovascular Aneurysm Repair
Actual Study Start Date : August 9, 2019
Estimated Primary Completion Date : December 9, 2019
Estimated Study Completion Date : December 9, 2020
Arms and Interventions
Group/Cohort Intervention/treatment
EVAR Patients
Patients with infrarenal abdominal aortic aneurysm scheduled for elective endovascular aneurysm repair (EVAR) surgery will undergo intraoperative assessments of aneurysm wall pulsatility using ultrasound M-Mode.
Diagnostic Test: Abdominal Aortic Aneurysm Sac Pulsatility

Measurements of aortic wall pulsatility will be performed using trans-abdominal ultrasound through the non-sterile field of the upper abdomen, while the surgeons operate through the groins. The pulsatilty of the aneurysm will then be measured using transverse views in 'M-Mode' of the ultrasound, and measures the aneurysm wall displacement during a cardiac cycle; the minimum diameter (diastole) and maximum diameter (systole) will be measured. These measurements will occur during surgery:

  1. Prior to EVAR deployment
  2. After EVAR deployment, but before balloon affixation to the aortic wall
  3. After EVAR deployment and after affixation
Other Name: M-Mode Ultrasound

Outcome Measures
Primary Outcome Measures :
  1. Fractional aneurysm sac size reduction 1 year after surgery [ Time Frame: 1 year ]
    Aneurysm sac size reduction will be measured using surveillance ultrasound 1 year after surgery. Post-operative imaging reports will be accessed through the hospital electronic health records system (EPIC).


Secondary Outcome Measures :
  1. Fractional aneurysm sac size reduction 30 days after surgery [ Time Frame: 30 days ]
    Aneurysm sac size reduction will be measured using CTA 30 days after surgery. Post-operative imaging reports will be accessed through the hospital electronic health records system (EPIC).

  2. Endovascular leaks (Type 1, 2, 3, 4) [ Time Frame: 30 days ]
    The presence of endovascular leaks (type 1, 2, 3, 4) will be assessed intraoperatively with a completion angiogram and CTA at 30 days postoperative. Postoperative imaging reports will be accessed through the hospital electronic heath records system (EPIC).

  3. Aneurysm-related re-interventions [ Time Frame: 1 year ]
    Any aneurysm-related complications requiring re-interventions will be noted. If an additional intervention is performed in the same operation, additional measurements of aortic wall pulsatility following intervention will be included. Other post-operative re-interventions will be reviewed through EPIC.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The study population will consist of anyone over the age of 18 years old with an abdominal aortic aneurysm scheduled for elective endovascular abdominal aortic aneurysm repair (EVAR) through the Division of Vascular & Endovascular Surgery at The Ottawa Hospital, Civic Campus.
Criteria

Inclusion Criteria:

  • Elective endovascular aneurysm repair (EVAR) surgery
  • Infrarenal abdominal aortic aneurysm
  • Age greater than 18 years old

Exclusion Criteria:

  • Prior abdominal aortic aneurysm procedures
  • Inability to visualize aneurysm on ultrasound
  • Inability to provide consent
  • Irregular arrhythmias
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Mark Rockley, MD 1-613-798-5555 mrockley@toh.ca

Locations
Layout table for location information
Canada, Ontario
The Ottawa Hospital - Civic Campus Recruiting
Ottawa, Ontario, Canada, K1Y 4E9
Contact: Mark Rockley, MD    1-613-798-5555    mrockley@toh.ca   
Sub-Investigator: Mark C Rockley, MD         
Sub-Investigator: Emily T Nham, BSc         
Sponsors and Collaborators
University of Ottawa
Tracking Information
First Submitted Date June 18, 2019
First Posted Date June 20, 2019
Last Update Posted Date August 28, 2019
Actual Study Start Date August 9, 2019
Estimated Primary Completion Date December 9, 2019   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: June 18, 2019)
Fractional aneurysm sac size reduction 1 year after surgery [ Time Frame: 1 year ]
Aneurysm sac size reduction will be measured using surveillance ultrasound 1 year after surgery. Post-operative imaging reports will be accessed through the hospital electronic health records system (EPIC).
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: June 18, 2019)
  • Fractional aneurysm sac size reduction 30 days after surgery [ Time Frame: 30 days ]
    Aneurysm sac size reduction will be measured using CTA 30 days after surgery. Post-operative imaging reports will be accessed through the hospital electronic health records system (EPIC).
  • Endovascular leaks (Type 1, 2, 3, 4) [ Time Frame: 30 days ]
    The presence of endovascular leaks (type 1, 2, 3, 4) will be assessed intraoperatively with a completion angiogram and CTA at 30 days postoperative. Postoperative imaging reports will be accessed through the hospital electronic heath records system (EPIC).
  • Aneurysm-related re-interventions [ Time Frame: 1 year ]
    Any aneurysm-related complications requiring re-interventions will be noted. If an additional intervention is performed in the same operation, additional measurements of aortic wall pulsatility following intervention will be included. Other post-operative re-interventions will be reviewed through EPIC.
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Intraoperative Assessment of Pulsatile Aneurysm Wall Motion During Endovascular Aneurysm Repair
Official Title Intraoperative Assessment of Pulsatile Aneurysm Wall Motion During Endovascular Aneurysm Repair
Brief Summary Endovascular abdominal aortic aneurysm repair (EVAR) aims to reduce the risk of aneurysm (AAA) rupture by reducing the blood pressure transmitted to the wall of the aneurysm. Aneurysms that remain pressurized despite EVAR may continue to grow, therefore requiring additional surgical interventions. The purpose of this study is to infer the reduction of pressure transmitted to the aneurysm wall by using intraoperative ultrasound ('M-Mode') to assess the pulsatility of the aneurysm wall. The hypothesis is that intraoperative reduction in aneurysm wall pulsatility after EVAR will correlate with improved aneurysm sac size reduction.
Detailed Description

Endovascular abdominal aortic aneurysm repair (EVAR) aims to reduce the risk of aneurysm (AAA) rupture by reducing the blood pressure transmitted to the wall of the aneurysm. Unfortunately, this procedure is not always successful, and patients need to return to the operating room for further procedures because the aneurysm wall remains pressurized and the aneurysm continues to grow. Currently, there is no standard non-invasive way of measuring aneurysm pressure. The purpose of this study is to infer the reduction of pressure transmitted to the aneurysm wall by using intraoperative ultrasound ('M-Mode') to assess the pulsatility of the aneurysm wall. The hypothesis is that intraoperative reduction in aneurysm wall pulsatility after EVAR will correlate with improved aneurysm sac size reduction. This is clinically relevant because physiologic intraoperative feedback of aneurysm pressure may potentially influence surgical decision making in the future, reducing unnecessary re-interventions. This will also improve our understanding of the intraoperative physiologic response to EVAR.

Our primary research question is in patients receiving elective endovascular repair of abdominal aortic aneurysms (EVAR), does the change in intraoperative ultrasound estimated aneurysm wall pressure during EVAR correlate with aneurysm sac size reduction 1 year after surgery? Secondary objectives are to assess correlation between intraoperative ultrasound estimated aneurysm wall pressure and endovascular leaks and aneurysm-related re-interventions.

A prospective, observational, assessor-blinded and surgeon-blinded study will be conducted at the TOH Civic Campus in Ottawa, ON in order to satisfy the objectives of the study.

Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population The study population will consist of anyone over the age of 18 years old with an abdominal aortic aneurysm scheduled for elective endovascular abdominal aortic aneurysm repair (EVAR) through the Division of Vascular & Endovascular Surgery at The Ottawa Hospital, Civic Campus.
Condition
  • Abdominal Aortic Aneurysm
  • Endovascular Abdominal Aortic Aneurysm Repair
  • Ultrasound
Intervention Diagnostic Test: Abdominal Aortic Aneurysm Sac Pulsatility

Measurements of aortic wall pulsatility will be performed using trans-abdominal ultrasound through the non-sterile field of the upper abdomen, while the surgeons operate through the groins. The pulsatilty of the aneurysm will then be measured using transverse views in 'M-Mode' of the ultrasound, and measures the aneurysm wall displacement during a cardiac cycle; the minimum diameter (diastole) and maximum diameter (systole) will be measured. These measurements will occur during surgery:

  1. Prior to EVAR deployment
  2. After EVAR deployment, but before balloon affixation to the aortic wall
  3. After EVAR deployment and after affixation
Other Name: M-Mode Ultrasound
Study Groups/Cohorts EVAR Patients
Patients with infrarenal abdominal aortic aneurysm scheduled for elective endovascular aneurysm repair (EVAR) surgery will undergo intraoperative assessments of aneurysm wall pulsatility using ultrasound M-Mode.
Intervention: Diagnostic Test: Abdominal Aortic Aneurysm Sac Pulsatility
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: June 18, 2019)
20
Original Estimated Enrollment Same as current
Estimated Study Completion Date December 9, 2020
Estimated Primary Completion Date December 9, 2019   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Elective endovascular aneurysm repair (EVAR) surgery
  • Infrarenal abdominal aortic aneurysm
  • Age greater than 18 years old

Exclusion Criteria:

  • Prior abdominal aortic aneurysm procedures
  • Inability to visualize aneurysm on ultrasound
  • Inability to provide consent
  • Irregular arrhythmias
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts
Contact: Mark Rockley, MD 1-613-798-5555 mrockley@toh.ca
Listed Location Countries Canada
Removed Location Countries  
 
Administrative Information
NCT Number NCT03993496
Other Study ID Numbers 20190366-01H
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
IPD Sharing Statement
Plan to Share IPD: No
Responsible Party Mark Rockley, University of Ottawa
Study Sponsor University of Ottawa
Collaborators Not Provided
Investigators Not Provided
PRS Account University of Ottawa
Verification Date August 2019